Page last updated: 2024-10-30

metformin and Chagas Disease

metformin has been researched along with Chagas Disease in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brima, W1
Eden, DJ1
Mehdi, SF1
Bravo, M1
Wiese, MM1
Stein, J1
Almonte, V1
Zhao, D1
Kurland, I1
Pessin, JE1
Zima, T1
Tanowitz, HB1
Weiss, LM1
Roth, J1
Nagajyothi, F1

Other Studies

1 other study available for metformin and Chagas Disease

ArticleYear
The brighter (and evolutionarily older) face of the metabolic syndrome: evidence from Trypanosoma cruzi infection in CD-1 mice.
    Diabetes/metabolism research and reviews, 2015, Volume: 31, Issue:4

    Topics: Adipose Tissue, White; Adiposity; Animals; Cell Line; Chagas Disease; Cytokines; Energy Metabolism;

2015